NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

"may not be able to complete the planned enrollment in this trial." I suppose RK could (and probably did) argue that this is consistent with not being able to finish enrollment in Germany if the patent was not granted.

It doesn't say "would not be able to enroll the planned number of patients for the trial", which they could get from some other country, "it says may not be able to complete the planned enrollment". Maybe that just means the further patients planned to be enrolled in Germany. That would make total sense for the language.

Then Pyrrho would, and I think did argue that it wouldn't make sense to put all countries on hold due to an issue in Germany....

Then RK, and maybe Senti would, and maybe did argue that maybe they want these further patients to all be from Germany... for some reason. I think Senti argued that the Germans may want to see a slow ramp in use of the new DC technology, and to accomplish that, they want all remaining patients in the planned trial size... or did I argue that... whatever. It sort of fits.

Nothing fits well, and it sort of fits.